161 related articles for article (PubMed ID: 23322564)
1. Safety of plasma exchange therapy in patients with myasthenia gravis.
Ebadi H; Barth D; Bril V
Muscle Nerve; 2013 Apr; 47(4):510-4. PubMed ID: 23322564
[TBL] [Abstract][Full Text] [Related]
2. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.
Dhawan PS; Goodman BP; Harper CM; Bosch PE; Hoffman-Snyder CR; Wellik KE; Wingerchuk DM; Demaerschalk BM
Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838
[TBL] [Abstract][Full Text] [Related]
3. IVIG and PLEX in the treatment of myasthenia gravis.
Bril V; Barnett-Tapia C; Barth D; Katzberg HD
Ann N Y Acad Sci; 2012 Dec; 1275():1-6. PubMed ID: 23278570
[TBL] [Abstract][Full Text] [Related]
4. Periodic therapeutic plasma exchange in patients with moderate to severe chronic myasthenia gravis non-responsive to immunosuppressive agents: an eight year follow-up.
Triantafyllou NI; Grapsa EI; Kararizou E; Psimenou E; Lagguranis A; Dimopoulos A
Ther Apher Dial; 2009 Jun; 13(3):174-8. PubMed ID: 19527462
[TBL] [Abstract][Full Text] [Related]
5. A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patients.
Alipour-Faz A; Shojaei M; Peyvandi H; Ramzi D; Oroei M; Ghadiri F; Peyvandi M
Acta Neurol Belg; 2017 Mar; 117(1):245-249. PubMed ID: 27530310
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
Jensen P; Bril V
J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
[TBL] [Abstract][Full Text] [Related]
7. Cost-minimization analysis comparing intravenous immunoglobulin with plasma exchange in the management of patients with myasthenia gravis.
Furlan JC; Barth D; Barnett C; Bril V
Muscle Nerve; 2016 Jun; 53(6):872-6. PubMed ID: 26521889
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of therapeutic options used for myasthenia gravis.
Mandawat A; Kaminski HJ; Cutter G; Katirji B; Alshekhlee A
Ann Neurol; 2010 Dec; 68(6):797-805. PubMed ID: 21061395
[TBL] [Abstract][Full Text] [Related]
9. Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis.
Liew WK; Powell CA; Sloan SR; Shamberger RC; Weldon CB; Darras BT; Kang PB
JAMA Neurol; 2014 May; 71(5):575-80. PubMed ID: 24590389
[TBL] [Abstract][Full Text] [Related]
10. Comparison of IVIg and PLEX in patients with myasthenia gravis.
Barth D; Nabavi Nouri M; Ng E; Nwe P; Bril V
Neurology; 2011 Jun; 76(23):2017-23. PubMed ID: 21562253
[TBL] [Abstract][Full Text] [Related]
11. Safety of intravenous immunoglobulin and plasma exchange in critically ill patients.
Clark SL; Rabinstein AA
Neurol Res; 2015 Jul; 37(7):593-8. PubMed ID: 25751423
[TBL] [Abstract][Full Text] [Related]
12. Changes in quality of life scores with intravenous immunoglobulin or plasmapheresis in patients with myasthenia gravis.
Barnett C; Wilson G; Barth D; Katzberg HD; Bril V
J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):94-7. PubMed ID: 23154126
[TBL] [Abstract][Full Text] [Related]
13. IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial.
Zinman L; Ng E; Bril V
Neurology; 2007 Mar; 68(11):837-41. PubMed ID: 17353471
[TBL] [Abstract][Full Text] [Related]
14. [Favorable results of plasmapheresis in severe myasthenia gravis].
Blom RJ; Kuks JB; Westerterp-Maas A; Oosterhuis HJ
Ned Tijdschr Geneeskd; 1997 Feb; 141(8):381-4. PubMed ID: 9157298
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of myasthenia gravis with intravenous immunoglobulin G (IVIG)].
Lavrnić DB; Stojanović V; Marinković Z; Pavlović S; Vidaković A; Apostolski S
Srp Arh Celok Lek; 1995; 123(5-6):146-8. PubMed ID: 17974459
[TBL] [Abstract][Full Text] [Related]
16. Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital.
Pittayanon R; Treeprasertsuk S; Phanthumchinda K
J Med Assoc Thai; 2009 Apr; 92(4):478-82. PubMed ID: 19374297
[TBL] [Abstract][Full Text] [Related]
17. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis.
Köhler W; Bucka C; Klingel R
J Clin Apher; 2011 Dec; 26(6):347-55. PubMed ID: 22095647
[TBL] [Abstract][Full Text] [Related]
18. Predictors of response to immunomodulation in patients with myasthenia gravis.
Katzberg HD; Barnett C; Bril V
Muscle Nerve; 2012 May; 45(5):648-52. PubMed ID: 22499090
[TBL] [Abstract][Full Text] [Related]
19. Plasma exchange in elderly patients.
Basic-Jukic N; Brunetta B; Kes P
Ther Apher Dial; 2010 Apr; 14(2):161-5. PubMed ID: 20438537
[TBL] [Abstract][Full Text] [Related]
20. Risk of thrombotic events after inpatient intravenous immunoglobulin or plasma exchange for neurologic disease: A case-crossover study.
Jin PH; Shin SC; Dhamoon MS
Muscle Nerve; 2020 Sep; 62(3):327-332. PubMed ID: 32270520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]